AstraZeneca Will Unite Vaccines, Antibody Therapies in New Division

AstraZeneca announced its plans to create a new, separate division for vaccines and antibody therapies. The focus will be on its COVID-19 vaccine developed with the University of Oxford and other COVID-19 antibody treatments.